title: Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases.
abstract: Dermatofibroma (cutaneous fibrous histiocytoma) represents a common benign mesenchymal tumor, and numerous morphological variants have been described. Some variants of dermatofibroma are characterized by an increased risk of local recurrences, and there are a few reported metastasizing cases. Unfortunately, an aggressive behavior cannot be predicted reliably by morphology at the moment, and we evaluated the value of array-comparative genomic hybridization (CGH) in this setting. Seven cases of clinically aggressive dermatofibromas were identified, and pathological and molecular features were evaluated. The neoplasms occurred in four female and in three male patients (mean age was 33 years, range 2-65 years), and arose on the shoulder, buttock, temple, lateral neck, thigh, ankle, and cheek. The size of the neoplasms ranged from 1 to 9 cm (mean: 3 cm). An infiltration of the subcutis was seen in five cases. Two neoplasms were completely excised, whereas an incomplete or marginal excision was reported in the remaining cases. Local recurrences were seen in six cases (time to the first recurrence ranged from 8 months to 9 years). Metastases were noted between 3 months and 8 years after diagnosis in six patients. Two patients died of disease, and two patients are alive with disease. Histologically, the primary tumors showed features of cellular dermatofibroma (four cases), cellular/aneurysmal dermatofibroma (one case), atypical/cellular dermatofibroma (one case), and classical dermatofibroma (one case). Mitotic figures ranged from 3 to 25 per 10 high-power fields, and focal necrosis was present in five cases. Interestingly, malignant transformation from cellular dermatofibroma to an obvious spindle cell/pleomorphic sarcoma was seen in one primary and in one recurrent neoplasm. Five neoplasms showed chromosomal aberrations by array-CGH, suggesting that these changes may represent an additional diagnostic tool in the recognition of cases of dermatofibroma with a metastatic potential.
authors.affiliation: Dermatopathology Bodensee Friedrichshafen, Friedrichshafen, Germany. mentzel@dermpath.de
authors.forename: Thomas
authors.initials: T
authors.lastname: Mentzel
authors.forename: Thomas
authors.initials: T
authors.lastname: Wiesner
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Cerroni
authors.forename: Markus
authors.initials: M
authors.lastname: Hantschke
authors.forename: Heinz
authors.initials: H
authors.lastname: Kutzner
authors.forename: Arno
authors.initials: A
authors.lastname: Rütten
authors.forename: Michael
authors.initials: M
authors.lastname: Häberle
authors.forename: Michele
authors.initials: M
authors.lastname: Bisceglia
authors.forename: Frederic
authors.initials: F
authors.lastname: Chibon
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Coindre
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D017809:Fatal Outcome; D005260:Female; D051677:Histiocytoma, Malignant Fibrous / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D016896:Treatment Outcome